The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR signaling pathway
The pathogenic mechanisms of pancreatic cancer (PC) are still not fully understood. Ubiquitination modifications have a crucial role in tumorigenesis and progression. Yet, the role of MINDY2, a member of the motif interacting with Ub-containing novel DUB family (MINDY), as a newly identified deubiqu...
Main Authors: | Peng Liu, Songbai Liu, Changhao Zhu, Yongning Li, Ying Li, Xiaobin Fei, Junyi Hou, Xing Wang, Yaozhen Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1169833/full |
Similar Items
-
Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01) -
Expression of mTOR in normal and pathological conditions
by: A Marques-Ramos, et al.
Published: (2023-07-01) -
PENGENDALIAN PENYAKIT KARAT PURU PADA BIBIT SENGON (Falcataria moluccana) DENGAN PRIMING BENIH DAN FUNGISIDA NABATI DAUN MINDI (Melia azedarach)
by: Fiona Azzahro, et al.
Published: (2020-07-01) -
Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
by: James T. Murray, et al.
Published: (2018-05-01) -
Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
by: Aleksandra Derwich, et al.
Published: (2023-03-01)